Investment Team
Scott Albert
Jeff Clark
Rich Brown
Grant Jackson
Chris Kroeger
Jan Bouten
Administrative Team
Lisa Lavallee
Colleen Suite
Sue Simon
Mike Gorman
Venture Partners
Doug Gooding
Richard Holcomb
Thomas McMurray
Greg Bohlen
William New
Advisory Boards
Life Science Advisory Board
Engineering Advisory Board
Venture Partners

Doug Gooding
Venture Partner

Doug serves as CEO at Regado Biosciences, one of Aurora’s portfolio companies.  As a Venture Partner for Aurora, he works primarily with Aurora's life science portfolio, specifically in the areas of biotechnology, drug discovery and development.  Doug serves on the Board of Directors of Cropsolution, Metabolon and Regado.

Prior to joining Aurora in 2001, he was a Director of Business Development at Paradigm Genetics (PDGM). Doug also spent four years at Incyte Pharmaceuticals (INCY), where he was the manager of the cDNA Library Construction Group. In addition, he worked as a Research Associate at Stratagene Cloning Systems in La Jolla, California.

Doug received a Bachelor of Arts in Biology, with a minor in Chemistry, from the University of San Diego and a MBA from the Kenan-Flagler Business School in Chapel Hill, NC.